Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laboratorios Farmacéuticos ROVI, S.A. announces strategic expansion and growth plans in a press release coinciding with its Ordinary General Shareholders’ Meeting. The company’s latest forecasts and business information can be accessed via their website. However, the company cautions that these forward-looking statements contain risks and uncertainties, and actual results may vary.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.